|
|
|
|
Virginia Tech Researchers Discover How Mosquitoes Avoid Succumbing To Viruses They Transmit
Mosquitoes are like Typhoid Mary.They can spread viruses which cause West Nile fever, dengue fever, or yellow fever without themselves getting sick. Scientists long thought that the mosquito didn't care whether...
|
|
|
Virginia Tech researchers discover how mosquitoes avoid succumbing to viruses they transmit
Blacksburg, Va.-- Mosquitoes are like Typhoid Mary. They can spread viruses which cause West Nile fever, dengue fever, or yellow fever without themselves getting sick. Scientists long thought that the mosquito...
|
|
|
Scientists Reveal How Mosquitoes Evade the Diseases They Transmit
Though it has been long thought that mosquitoes are oblivious to the viruses they transmit, Virginia Tech researchers have shown that they actively fight against the infection by cutting strands of code at the cellular level.Virus-derived...
|
|
|
K-STATE: CDC Researcher at K-State Symposium: The Increases in Genomic Diversity in The Virus That Causes Rift
K-State Symposium: The Increases in Genomic Diversity in The Virus That Causes Rift Valley Fever Highlight The Need for Safe, Effective Vaccines cookieGood (navigator.cookieEnabled cookieGood 0) TMC Launches New Sites: EXPO East begins...
|
|
|
Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting
- Patent for Antibodies that Directly Bind to Phospholipid Targets Covers All Viral Infections and All Combination Regimens - - Patent Issuance Follows Nature Medicine Publication Confirming the Broad Anti-Viral Potential of Anti...
|
|
|
Researchers predict vaccine's immunity
researchers say they've discovered a way to predict how successful vaccines would be in triggering immune responses.In the first-ever study, researchers at the Yerkes National Primate Research Center and Emory Vaccine Center at Emory...
|
|
|
Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting
- Patent for Antibodies that Directly Bind to Phospholipid Targets Covers All Viral Infections and All Combination Regimens - TUSTIN, Calif., November 25, 2008 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc., a clinical...
|
|
|
Researchers predict vaccine's immunity
ATLANTA, Nov.24 (UPI) -- U.S. researchers say they've discovered a way to predict how successful vaccines would be in triggering immune responses. In the first-ever study, researchers at the Yerkes National Primate Research Center and...
|
|
|
Researchers Discover Strategy for Predicting the Immunity of Vaccines
In the first study of its kind, researchers at the Yerkes National Primate Research Center and Emory Vaccine Center, Emory University, have developed a multidisciplinary approach involving immunology, genomics and bioinformatics to predict...
|
|
|
Strategy For Predicting Immunity Of Vaccines Developed
ScienceDaily (Nov.23, 2008) In the first study of its kind, researchers at the Yerkes National Primate Research Center and Emory Vaccine Center, Emory University, have developed a multidisciplinary approach involving immunology, genomics...
|
|
|
Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal
--PS-Targeting Antibodies May Represent a Completely New Class of Drugs with Broad Potential to Treat Life-Threatening Viral Infections-- --Peregrine's Clinical-Stage Anti-PS Agent Bavituximab and Equivalent Antibodies Cured Lethal...
|
|
|
Peregrine's Anti-Viral Bavituximab in Nature Medicine
Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals Bavituximab to Cure Lethal Virus Infections PS-Targeting Antibodies May Represent a Completely New Class of Drugs with Broad Potential to Treat Life...
|
|
|
Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab
--PS-Targeting AntibodiesMay Represent a Completely New Class of Drugs with Broad Potential to Treat Life-Threatening Viral Infections-- --Peregrine's Clinical-Stage Anti-PS Agent Bavituximab and Equivalent Antibodies Cured Lethal...
|
|
|
Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal
--PS-Targeting AntibodiesMay Represent a Completely New Class of Drugs with Broad Potential to Treat Life-Threatening Viral Infections-- --Peregrine's Clinical-Stage Anti-PS Agent Bavituximab and Equivalent Antibodies Cured Lethal...
|
|
|
Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal
TUSTIN, Calif., Nov.24 CA-PeregrineVirusData --PS-Targeting Antibodies May Represent a Completely New Class of Drugs with Broad Potential to Treat Life-Threatening Viral Infections-- --Peregrine's Clinical-Stage Anti-PS Agent...
|
|
|
Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal
--PS-Targeting Antibodies May Represent a Completely New Class of Drugs with Broad Potential to Treat Life-Threatening Viral Infections-- --Peregrine's Clinical-Stage Anti-PS Agent Bavituximab and Equivalent Antibodies Cured Lethal...
|
|
|
Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal
--PS-Targeting Antibodies May Represent a Completely New Class of Drugs with Broad Potential to Treat Life-Threatening Viral Infections-- --Peregrine's Clinical-Stage Anti-PS Agent Bavituximab and Equivalent Antibodies Cured Lethal...
|
|
|
Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal
--PS-Targeting Antibodies May Represent a Completely New Class of Drugs with Broad Potential to Treat Life-Threatening Viral Infections-- --Peregrine's Clinical-Stage Anti-PS Agent Bavituximab and Equivalent Antibodies Cured Lethal...
|
|
|
Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal
--PS-Targeting Antibodies May Represent a Completely New Class of Drugs with Broad Potential to Treat Life-Threatening Viral Infections-- --Peregrine's Clinical-Stage Anti-PS Agent Bavituximab and Equivalent Antibodies Cured Lethal...
|
|
|
Researchers discover strategy for predicting the immunity of vaccines
In the first study of its kind, researchers at the Yerkes National Primate Research Center and Emory Vaccine Center, Emory University, have developed a multidisciplinary approach involving immunology, genomics and bioinformatics to predict...
|
|
|
Researchers discover strategy for predicting the immunity of vaccines
In the first study of its kind, researchers at the Yerkes National Primate Research Center and Emory Vaccine Center, Emory University, have developed a multidisciplinary approach involving immunology, genomics and bioinformatics to predict...
|
|
|
New U.S. Army Mosquito Control Technology Licensed for DeploymentAgainst Dengue
A novel, patented mosquito-killing technology developed by U.S.Army researchers under a long-term, joint-development agreement between the , the , and the , and targeted at Dengue fever is headed for the field. This technology can...
|
|
|
Yellow Fever Epidemiology - New yellow fever epidemiology study findings reported from Centers for Disease Con
Fresh data on yellow fever are presented in the report 'An of yellow fever with concurrent chikungunya transmission in South Kordofan, Sudan, 2005.' According to recent research published in the journal Transactions...
|
|
|
Drugs and Medicines Used in Amoebiasis and Other Protozoal Infections
Amebiasis is an infectious disease caused by a parasitic one-celled microorganism (protozoan) called Entamoeba histolytica.Persons with amebiasis may experience a wide range of symptoms, including diarrhea, fever, and cramps. The...
|
|
|
New yellow fever epidemiology study findings reported from Centers for Disease Control and Prevention
- (NewsRx.com) -- Fresh data on yellow fever are presented in the report 'An outbreak of yellow fever with concurrent chikungunya virus transmission in South Kordofan, Sudan, 2005.' According to recent research...
|
